Publications by authors named "Justin Ady"

Claim this Profile
A
Area Deprivation Index is not predictive of worse outcomes after open lower extremity revascularization.
Nadia K Palte, Lily S F Adler, Justin W Ady, Huong Truong, Saum A Rahimi

J Vasc Surg· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern mortality risk stratification scores accurately and equally predict real-world postoperative mortality after ruptured abdominal aortic aneurysm.
Michael A Ciaramella, Daniel Ventarola, Justin Ady, Saum Rahimi, William E Beckerman

J Vasc Surg· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant Aorto-Caval Reconstruction for Inferior Vena Cava Leiomyosarcoma.
Anthony N Grieff, Charles Hamilton, Justin Ady, William E Beckerman, Randy Shafritz

Ann Vasc Surg· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tunneling nanotubes: an alternate route for propagation of the bystander effect following oncolytic viral infection.
Justin Ady, Venugopal Thayanithy, Kelly Mojica, Phillip Wong, Joshua Carson

Mol Ther Oncolytics· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic viral therapy for pancreatic cancer: current research and future directions.
Justin W Ady, Jacqueline Heffner, Elizabeth Klein, Yuman Fong

Oncolytic Virother· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma.
Amudhan Pugalenthi, Kelly Mojica, Justin W Ady, Clark Johnsen, Damon Love

Cancer Gene Ther· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma.
Justin W Ady, Clark Johnsen, Kelly Mojica, Jacqueline Heffner, Damon Love

Surgery· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis.
Clarisse Eveno, Kelly Mojica, Justin W Ady, Daniel L J Thorek, Valerie Longo

Surgery· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging for infection: from visualization of inflammation to visualization of microbes.
Justin Ady, Yuman Fong

Surg Infect (Larchmt)· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intercellular communication in malignant pleural mesothelioma: properties of tunneling nanotubes.
Justin W Ady, Snider Desir, Venugopal Thayanithy, Rachel I Vogel, André L Moreira

Front Physiol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic immunotherapy using recombinant vaccinia virus GLV-1h68 kills sorafenib-resistant hepatocellular carcinoma efficiently.
Justin W Ady, Jacqueline Heffner, Kelly Mojica, Clark Johnsen, Laurence J Belin

Surgery· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An oncolytic vaccinia virus expressing the human sodium iodine symporter prolongs survival and facilitates SPECT/CT imaging in an orthotopic model of malignant pleural mesothelioma.
Laurence J Belin, Justin W Ady, Christina Lewis, Drew Marano, Sepideh Gholami

Surgery· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis